Abstract
Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting.
Publication types
-
Practice Guideline
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adolescent
-
Antitubercular Agents / pharmacology
-
Antitubercular Agents / therapeutic use*
-
Child
-
Child, Preschool
-
Drug Therapy, Combination / methods
-
Humans
-
Infant
-
Infant, Newborn
-
Mycobacterium tuberculosis / drug effects*
-
Mycobacterium tuberculosis / isolation & purification
-
Pediatrics / methods*
-
Tuberculosis, Multidrug-Resistant / diagnosis*
-
Tuberculosis, Multidrug-Resistant / drug therapy*